Lectin-based biosensors as analytical tools for clinical oncology

MLS Silva - Cancer letters, 2018 - Elsevier
The review focus on the use of lectin-based biosensors in the oncology field, and ponders
the potentialities of using these devices as analytical tools to monitor the levels of cancer …

Deciphering the molecular nature of ovarian cancer biomarker CA125

F Weiland, K Martin, MK Oehler… - International Journal of …, 2012 - mdpi.com
The ovarian cancer biomarker CA125 has been extensively investigated over the last 30
years. The knowledge about the exact molecular nature of this protein, however, remains …

[HTML][HTML] Current status of lectin-based cancer diagnosis and therapy

FS Coulibaly, BBC Youan - AIMS Molecular Science, 2017 - aimspress.com
Lectins are carbohydrate recognizing proteins originating from diverse origins in nature,
including animals, plants, viruses, bacteria and fungus. Due to their exceptional glycan …

Exploring the glycosylation of serum CA125

R Saldova, WB Struwe, K Wynne, G Elia… - International Journal of …, 2013 - mdpi.com
Ovarian cancer is the most lethal gynaecologic cancer affecting women. The most widely
used biomarker for ovarian cancer, CA125, lacks sensitivity and specificity. Here, we …

Integrated microfluidic lectin barcode platform for high-performance focused glycomic profiling

Y Shang, Y Zeng, Y Zeng - Scientific reports, 2016 - nature.com
Protein glycosylation is one of the key processes that play essential roles in biological
functions and dysfunctions. However, progress in glycomics has considerably lagged …

[HTML][HTML] High-sensitivity profiling of glycoproteins from ovarian cancer sera using lectin-affinity and LC-ESI-Q-TOF-MS/MS

AN Roopashri, MS Divyashree, J Savitha - Current Research in …, 2023 - Elsevier
Lectins act as effective diagnostic tools for screening potential cancer biomarkers because
of their ability to recognize the carbohydrate moiety of glycoproteins present in most complex …

Methods for identification of CA125 from ovarian cancer ascites by high resolution mass spectrometry

F Weiland, K Fritz, MK Oehler, P Hoffmann - International Journal of …, 2012 - mdpi.com
CA125 is the most widely used tumour marker in ovarian cancer with unsatisfactory
sensitivity and specificity especially at early stage. It is quantified by antibody-based …

Conflicting views on the molecular structure of the cancer antigen CA125/MUC16

H Bouanene, A Miled - Disease markers, 2010 - content.iospress.com
CA125 is a tumor antigen used to monitor the progression and regression of epithelial
ovarian cancer. Despite the widespread use of CA125, the biochemical and molecular …

[图书][B] Noninvasive Molecular Markers in Gynecologic Cancers

D Barh, M Gunduz - 2015 - books.google.com
In cancer treatment, non-invasive diagnosis can avoid complications of biopsy and other
unfavorable impacts on patient's health. DNA, methylation, SNPs, miRNA, mRNA, protein …

Nano-sized CA125 antigen glycocamouflage: Mucin-Extracellular vesicles alliance to watch?

N Mitić, M Kosanović, B Milutinović, S Goč… - Archives of biochemistry …, 2018 - Elsevier
Abstract Mucin 16 (MUC16) is a transmembrane type mucin and its released extracellular
portion is designated as CA125 antigen. It is considered to be part of a supramolecular …